首页> 美国卫生研究院文献>Proceedings of the National Academy of Sciences of the United States of America >CD4 peptide-protein conjugates but not recombinant human CD4 bind to recombinant gp120 from the human immunodeficiency virus in the presence of serum from AIDS patients.
【2h】

CD4 peptide-protein conjugates but not recombinant human CD4 bind to recombinant gp120 from the human immunodeficiency virus in the presence of serum from AIDS patients.

机译:在艾滋病患者的血清中CD4肽-蛋白质结合物而非重组人CD4与人免疫缺陷病毒的重组gp120结合。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Sera from human immunodeficiency virus-positive (HIV+; Walter Reed stage 6) individuals inhibit the interaction between recombinant human CD4 and recombinant gp120 from HIV (rCD4 and rgp120, respectively), thereby interfering with the ability of soluble rCD4 to block infection with HIV or rCD4-toxin conjugates to kill HIV-infected cells. In this report we demonstrate that the inhibitory activity of such sera is caused primarily by anti-gp120 antibodies that do not recognize the CD4 interaction site on gp120. To circumvent the problem of inhibition, we have generated a construct containing a peptide of CD4 (residues 41-84) conjugated to ovalbumin (three to five peptides per molecule). This multivalent conjugate binds to rgp120 and binding is not inhibited by antibodies in HIV+ sera.
机译:来自人类免疫缺陷病毒阳性(HIV +; Walter Reed 6期)个体的血清抑制了重组人CD4和来自HIV的重组gp120(分别为rCD4和rgp120)之间的相互作用,从而干扰了可溶性rCD4阻断HIV感染的能力。 rCD4-毒素偶联物可杀死感染HIV的细胞。在此报告中,我们证明了这种血清的抑制活性主要是由不识别gp120上CD4相互作用位点的抗gp120抗体引起的。为了避免抑制问题,我们产生了含有与卵白蛋白缀合的CD4肽(残基41-84)的构建体(每个分子三至五个肽)。该多价结合物与rgp120结合,并且结合不受HIV +血清中的抗体的抑制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号